{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:01:22Z","timestamp":1790186482564,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11102-026-01678-6","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T19:53:06Z","timestamp":1779565986000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Determinants of remission and recurrence following transsphenoidal surgery for prolactinoma: a single-center experience"],"prefix":"10.1007","volume":"29","author":[{"given":"William M.","family":"Burns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurkirat","family":"Kohli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kassis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Contento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanth","family":"Romiyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Lopa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismat","family":"Shafiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Edward","family":"Vates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"issue":"8","key":"1678_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2023.102919","volume":"54","author":"IM Zandbergen","year":"2023","unstructured":"Zandbergen IM, Huntoon KM, White TG et al (2023) Efficacy and safety of endoscopic transsphenoidal resection for prolactinoma: a retrospective multicenter case-series. Arch Med Res 54(8):102919. https:\/\/doi.org\/10.1016\/j.arcmed.2023.102919","journal-title":"Arch Med Res"},{"key":"1678_CR2","doi-asserted-by":"publisher","first-page":"e858","DOI":"10.1016\/j.wneu.2022.12.003","volume":"170","author":"A Uzuner","year":"2023","unstructured":"Uzuner A, Yilmaz E, Caklili M et al (2023) Endoscopic transnasal approach for microprolactinomas with experience of 105 cases in a single center: paradigmal shift for conventional medical therapy. World Neurosurg 170:e858\u2013e867. https:\/\/doi.org\/10.1016\/j.wneu.2022.12.003","journal-title":"World Neurosurg"},{"issue":"5","key":"1678_CR3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1210\/er.2005-9998","volume":"27","author":"MP Gillam","year":"2006","unstructured":"Gillam MP, Molitch ME, Lombardi G, Colao A (2006) Advances in the treatment of prolactinomas. Endocr Rev 27(5):485\u2013534. https:\/\/doi.org\/10.1210\/er.2005-9998","journal-title":"Endocr Rev"},{"issue":"3","key":"1678_CR4","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s12020-014-0281-3","volume":"47","author":"R Salvatori","year":"2014","unstructured":"Salvatori R (2014) Surgical treatment of microprolactinomas: pros. Endocrine 47(3):725\u2013729. https:\/\/doi.org\/10.1007\/s12020-014-0281-3","journal-title":"Endocrine"},{"key":"1678_CR5","doi-asserted-by":"publisher","first-page":"e349","DOI":"10.1016\/j.wneu.2021.07.035","volume":"154","author":"K Wright","year":"2021","unstructured":"Wright K, Chaker L, Pacione D et al (2021) Determinants of surgical remission in prolactinomas: a systematic review and meta-analysis. World Neurosurg 154:e349\u2013e369. https:\/\/doi.org\/10.1016\/j.wneu.2021.07.035","journal-title":"World Neurosurg"},{"issue":"1","key":"1678_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-023-02033-0","volume":"46","author":"M Ottenhausen","year":"2023","unstructured":"Ottenhausen M, Conrad J, Wolters LM, Ringel F (2023) Surgery as first-line treatment for prolactinoma? Discussion of the literature and results of a consecutive series of surgically treated patients. Neurosurg Rev 46(1):128. https:\/\/doi.org\/10.1007\/s10143-023-02033-0","journal-title":"Neurosurg Rev"},{"issue":"8","key":"1678_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3349\/ymj.2022.0406","volume":"64","author":"EH Kim","year":"2023","unstructured":"Kim EH, Kim J, Ku CR, Lee EJ, Kim SH (2023) Surgical treatment of prolactinomas: potential role as a first-line treatment modality. Yonsei Med J 64(8):489\u2013496. https:\/\/doi.org\/10.3349\/ymj.2022.0406","journal-title":"Yonsei Med J"},{"issue":"3","key":"1678_CR8","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1210\/clinem\/dgz144","volume":"105","author":"AH Zamanipoor Najafabadi","year":"2020","unstructured":"Zamanipoor Najafabadi AH, Zandbergen IM, de Vries F et al (2020) Surgery as a viable alternative first-line treatment for prolactinoma patients. a systematic review and meta-analysis. J Clin Endocrinol Metab 105(3):e32\u2013e41. https:\/\/doi.org\/10.1210\/clinem\/dgz144","journal-title":"J Clin Endocrinol Metab"},{"key":"1678_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00636","volume":"9","author":"Q Ma","year":"2018","unstructured":"Ma Q, Su J, Li Y et al (2018) The chance of permanent cure for micro- and macroprolactinomas, medication or surgery? A systematic review and meta-analysis. Front Endocrinol (Lausanne) 9:636. https:\/\/doi.org\/10.3389\/fendo.2018.00636","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"1678_CR10","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1530\/EJE-21-0293","volume":"185","author":"B Baussart","year":"2021","unstructured":"Baussart B, Villa C, Jouinot A et al (2021) Pituitary surgery as alternative to dopamine agonists treatment for microprolactinomas: a cohort study. Eur J Endocrinol 185(6):783\u2013791. https:\/\/doi.org\/10.1530\/EJE-21-0293","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"1678_CR11","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","volume":"19","author":"S Petersenn","year":"2023","unstructured":"Petersenn S, Fleseriu M, Casanueva FF et al (2023) Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat Rev Endocrinol 19(12):722\u2013740. https:\/\/doi.org\/10.1038\/s41574-023-00886-5","journal-title":"Nat Rev Endocrinol"},{"key":"1678_CR12","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2021.36.e97","author":"K Park","year":"2021","unstructured":"Park K, Park KH, Park HR et al (2021) Long-term outcome of microscopic transsphenoidal surgery for prolactinomas as an alternative to dopamine agonists. J Korean Med Sci. https:\/\/doi.org\/10.3346\/jkms.2021.36.e97","journal-title":"J Korean Med Sci"},{"key":"1678_CR13","doi-asserted-by":"publisher","unstructured":"Osorio RC, Haddad AF, Hart DM et al (2024) Socioeconomic differences between medically and surgically treated prolactinomas: a retrospective review of 598 patients. J Neurosurg. https:\/\/doi.org\/10.3171\/2023.6.JNS23570","DOI":"10.3171\/2023.6.JNS23570"},{"issue":"5","key":"1678_CR14","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1530\/EJE-11-1000","volume":"166","author":"V Primeau","year":"2012","unstructured":"Primeau V, Raftopoulos C, Maiter D (2012) Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients. Eur J Endocrinol 166(5):779\u2013786. https:\/\/doi.org\/10.1530\/EJE-11-1000","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"1678_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1530\/EJE-07-0248","volume":"158","author":"J Kreutzer","year":"2008","unstructured":"Kreutzer J, Buslei R, Wallaschofski H et al (2008) Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients. Eur J Endocrinol 158(1):11\u201318. https:\/\/doi.org\/10.1530\/EJE-07-0248","journal-title":"Eur J Endocrinol"},{"key":"1678_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1055\/a-1247-4908","volume":"129","author":"S Giese","year":"2021","unstructured":"Giese S, Nasi-Kordhishti I, Honegger J (2021) Outcomes of transsphenoidal microsurgery for prolactinomas \u2013 a contemporary series of 162 cases. Exp Clin Endocrinol Diabetes 129:163\u2013171. https:\/\/doi.org\/10.1055\/a-1247-4908","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"5","key":"1678_CR17","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1210\/jcem.81.5.8626821","volume":"81","author":"SL Feigenbaum","year":"1996","unstructured":"Feigenbaum SL, Downey DE, Wilson CB, Jaffe RB (1996) Transsphenoidal pituitary resection for preoperative diagnosis of prolactin-secreting pituitary adenoma in women: long term follow-up. J Clin Endocrinol Metab 81(5):1711\u20131719. https:\/\/doi.org\/10.1210\/jcem.81.5.8626821","journal-title":"J Clin Endocrinol Metab"},{"key":"1678_CR18","doi-asserted-by":"publisher","DOI":"10.3171\/2011.1.FOCUS10317","author":"CP Hofstetter","year":"2011","unstructured":"Hofstetter CP, Shin BJ, Mubita L et al (2011) Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas. Neurosurg Focus. https:\/\/doi.org\/10.3171\/2011.1.FOCUS10317","journal-title":"Neurosurg Focus"},{"issue":"10","key":"1678_CR19","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvab074","volume":"5","author":"MC Penn","year":"2021","unstructured":"Penn MC, Cardinal T, Zhang Y et al (2021) Cure and hormonal control after prolactinoma resection: case series and systematic review. J Endocr Soc 5(10):bvab074. https:\/\/doi.org\/10.1210\/jendso\/bvab074","journal-title":"J Endocr Soc"},{"issue":"2","key":"1678_CR20","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3171\/jns.2002.97.2.0307","volume":"97","author":"AP Amar","year":"2002","unstructured":"Amar AP, Couldwell WT, Chen JCT, Weiss MH (2002) Predictive value of serum prolactin levels measured immediately after transsphenoidal surgery. J Neurosurg 97(2):307\u2013314. https:\/\/doi.org\/10.3171\/jns.2002.97.2.0307","journal-title":"J Neurosurg"},{"key":"1678_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.810219","author":"M Huber","year":"2022","unstructured":"Huber M, Luedi MM, Schubert GA et al (2022) Machine learning for outcome prediction in first-line surgery of prolactinomas. Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2022.810219","journal-title":"Front Endocrinol"},{"issue":"3","key":"1678_CR22","doi-asserted-by":"publisher","first-page":"204","DOI":"10.14791\/btrt.2023.0023","volume":"11","author":"GY Lee","year":"2023","unstructured":"Lee GY, Kim SH, Kim EH (2023) Role of immediate postoperative prolactin measurement in female prolactinoma patients: predicting long-term remission after complete tumor removal. Brain Tumor Res Treat 11(3):204\u2013209. https:\/\/doi.org\/10.14791\/btrt.2023.0023","journal-title":"Brain Tumor Res Treat"},{"issue":"7","key":"1678_CR23","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1001\/jama.1984.03350070039020","volume":"252","author":"EF Rodman","year":"1984","unstructured":"Rodman EF, Molitch ME, Post KD, Biller BJ, Reichlin S (1984) Long-term follow-up of transsphenoidal selective adenomectomy for prolactinoma. JAMA 252(7):921\u2013924. https:\/\/doi.org\/10.1001\/jama.1984.03350070039020","journal-title":"JAMA"},{"issue":"1","key":"1678_CR24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4158\/EP161446.OR","volume":"23","author":"D Donegan","year":"2017","unstructured":"Donegan D, Atkinson JD, Jentoft M et al (2017) Surgical outcomes of prolactinomas in recent era: results of a heterogenous group. Endocr Pract 23(1):37\u201345. https:\/\/doi.org\/10.4158\/EP161446.OR","journal-title":"Endocr Pract"},{"key":"1678_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9930059","volume":"2021","author":"J Lu","year":"2021","unstructured":"Lu J, Cai L, Wu Z et al (2021) Surgery and medical treatment in microprolactinoma: a systematic review and meta-analysis. Int J Endocrinol 2021:9930059. https:\/\/doi.org\/10.1155\/2021\/9930059","journal-title":"Int J Endocrinol"},{"key":"1678_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2023.108079","volume":"236","author":"MC Findlay","year":"2024","unstructured":"Findlay MC, Sabahi M, Azab M et al (2024) The role of surgical management for prolactin-secreting tumors in the era of dopaminergic agonists: an international multicenter report. Clin Neurol Neurosurg 236:108079. https:\/\/doi.org\/10.1016\/j.clineuro.2023.108079","journal-title":"Clin Neurol Neurosurg"},{"issue":"11","key":"1678_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13427","volume":"36","author":"I Shafiq","year":"2024","unstructured":"Shafiq I, Williams ZR, Vates GE (2024) Advancement in perioperative management of pituitary adenomas-current concepts and best practices. J Neuroendocrinol 36(11):e13427. https:\/\/doi.org\/10.1111\/jne.13427","journal-title":"J Neuroendocrinol"},{"issue":"8","key":"1678_CR28","doi-asserted-by":"publisher","first-page":"897","DOI":"10.4158\/EP15652.OR","volume":"21","author":"E Manuylova","year":"2015","unstructured":"Manuylova E, Calvi LM, Vates GE, Hastings C, Shafiq I (2015) MORNING serum cortisol level after transsphenoidal surgery for pituitary adenoma predicts hypothalamic-pituitary-adrenal function despite intraoperative dexamethasone use. Endocr Pract 21(8):897\u2013902. https:\/\/doi.org\/10.4158\/EP15652.OR","journal-title":"Endocr Pract"},{"issue":"4","key":"1678_CR29","doi-asserted-by":"publisher","first-page":"899","DOI":"10.21608\/ejhm.2019.25556","volume":"74","author":"MR Kandeel","year":"2019","unstructured":"Kandeel MR, Elhawary MA, Elghannam O (2019) Does Dopamine Agonist Hormonal Therapy for Macro-Prolactinoma Affect Future Surgery? Egypt J Hosp Med 74(4):899\u2013904. https:\/\/doi.org\/10.21608\/ejhm.2019.25556","journal-title":"Egypt J Hosp Med"},{"key":"1678_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00439","author":"G Zielinski","year":"2020","unstructured":"Zielinski G, Ozdarski M, Maksymowicz M, Szamotulska K, Witek P (2020) Prolactinomas: prognostic factors of early remission after transsphenoidal surgery. Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2020.00439","journal-title":"Front Endocrinol"},{"issue":"3","key":"1678_CR31","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s11102-022-01221-3","volume":"25","author":"H Abou-Al-Shaar","year":"2022","unstructured":"Abou-Al-Shaar H, Mallela AN, Patel A et al (2022) The role of endoscopic endonasal surgery in the management of prolactinomas based on their invasiveness into the cavernous sinus. Pituitary 25(3):508\u2013519. https:\/\/doi.org\/10.1007\/s11102-022-01221-3","journal-title":"Pituitary"},{"key":"1678_CR32","doi-asserted-by":"publisher","first-page":"e626","DOI":"10.1016\/j.wneu.2022.10.043","volume":"168","author":"BK Force","year":"2022","unstructured":"Force BK, Staggers K, Sebastian S, Takashima M, Yoshor D, Samson SL (2022) Endoscopic Endonasal Transsphenoidal Surgery for Patients with Prolactinomas: Indications and Outcomes. World Neurosurg 168:e626\u2013e635. https:\/\/doi.org\/10.1016\/j.wneu.2022.10.043","journal-title":"World Neurosurg"},{"key":"1678_CR33","doi-asserted-by":"publisher","DOI":"10.3171\/2023.3.JNS221949","author":"K Asmaro","year":"2023","unstructured":"Asmaro K, Zhang M, Rodrigues AJ et al (2023) Cytodifferentiation of pituitary tumors influences pathogenesis and cavernous sinus invasion. J Neurosurg. https:\/\/doi.org\/10.3171\/2023.3.JNS221949","journal-title":"J Neurosurg"},{"key":"1678_CR34","doi-asserted-by":"publisher","DOI":"10.3171\/2022.8.JNS221890","author":"RC Osorio","year":"2023","unstructured":"Osorio RC, Pereira MP, Oh T et al (2023) Correlation between tumor volume and serum prolactin and its effect on surgical outcomes in a cohort of 219 prolactinoma patients. J Neurosurg. https:\/\/doi.org\/10.3171\/2022.8.JNS221890","journal-title":"J Neurosurg"},{"issue":"10","key":"1678_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci12101354","volume":"12","author":"LJM de Mac\u00eado Filho","year":"2022","unstructured":"de Mac\u00eado Filho LJM, Di\u00f3genes AVG, Barreto EG et al (2022) Endoscopic Endonasal Resection of the Medial Wall of the Cavernous Sinus and Its Impact on Outcomes of Pituitary Surgery: A Systematic Review and Meta-Analysis. Brain Sci 12(10):1354. https:\/\/doi.org\/10.3390\/brainsci12101354","journal-title":"Brain Sci"},{"key":"1678_CR36","doi-asserted-by":"publisher","unstructured":"Burke WT, Penn DL, Castlen JP et al (2020) Prolactinomas and nonfunctioning adenomas: preoperative diagnosis of tumor type using serum prolactin and tumor size. J Neurosurg. https:\/\/doi.org\/10.3171\/2019.3.JNS19121","DOI":"10.3171\/2019.3.JNS19121"},{"key":"1678_CR37","doi-asserted-by":"publisher","unstructured":"Biagetti B, Sim\u00f2 R (2021) Molecular Pathways in Prolactinomas: Translational and Therapeutic Implications. Int J Mol Sci 22(20):20. https:\/\/doi.org\/10.3390\/ijms222011247","DOI":"10.3390\/ijms222011247"},{"issue":"1","key":"1678_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16052-8","volume":"11","author":"C Li","year":"2020","unstructured":"Li C, Xie W, Rosenblum JS et al (2020) Somatic SF3B1 hotspot mutation in prolactinomas. Nat Commun 11(1):2506. https:\/\/doi.org\/10.1038\/s41467-020-16052-8","journal-title":"Nat Commun"},{"issue":"15","key":"1678_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14153604","volume":"14","author":"N Fukuhara","year":"2022","unstructured":"Fukuhara N, Nishiyama M, Iwasaki Y (2022) Update in Pathogenesis, Diagnosis, and Therapy of Prolactinoma. Cancers 14(15):15. https:\/\/doi.org\/10.3390\/cancers14153604","journal-title":"Cancers"},{"issue":"1","key":"1678_CR40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4158\/EP13165.RA","volume":"20","author":"R Carija","year":"2014","unstructured":"Carija R, Tudor M, Vucina D (2014) Effect of the Preoperative Use of Dopamine Agonists in the Postoperative Course of Prolactinomas: A Systematic Review. Endocr Pract 20(1):70\u201374. https:\/\/doi.org\/10.4158\/EP13165.RA","journal-title":"Endocr Pract"},{"issue":"1","key":"1678_CR41","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11102-010-0261-4","volume":"14","author":"M Menucci","year":"2011","unstructured":"Menucci M, Qui\u00f1ones-Hinojosa A, Burger P, Salvatori R (2011) Effect of dopaminergic drug treatment on surgical findings in prolactinomas. Pituitary 14(1):68\u201374. https:\/\/doi.org\/10.1007\/s11102-010-0261-4","journal-title":"Pituitary"},{"key":"1678_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-020-0543-4","author":"E Vermeulen","year":"2020","unstructured":"Vermeulen E, D\u2019Haens J, Stadnik T et al (2020) Predictors of dopamine agonist resistance in prolactinoma patients. BMC Endocr Disord. https:\/\/doi.org\/10.1186\/s12902-020-0543-4","journal-title":"BMC Endocr Disord"},{"issue":"4","key":"1678_CR43","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1227\/01.NEU.0000325725.77132.90","volume":"63","author":"N Fatemi","year":"2008","unstructured":"Fatemi N, Dusick JR, Mattozo C et al (2008) Pituitary hormonal loss and recovery after transsphenoidal adenoma removal. Neurosurgery 63(4):709\u2013718. https:\/\/doi.org\/10.1227\/01.NEU.0000325725.77132.90","journal-title":"Neurosurgery"},{"issue":"9","key":"1678_CR44","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1111\/jgs.13590","volume":"63","author":"J Liu","year":"2015","unstructured":"Liu J, Li C, Xiao Q et al (2015) Comparison of pituitary adenomas in elderly and younger adults: clinical characteristics, surgical outcomes, and prognosis. J Am Geriatr Soc 63(9):1924\u20131930. https:\/\/doi.org\/10.1111\/jgs.13590","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"1678_CR45","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1210\/en.2015-2059","volume":"157","author":"BS Ellsworth","year":"2016","unstructured":"Ellsworth BS (2016) Pituitary regeneration: it\u2019ll knock your SOX off! Endocrinology 157(2):452\u2013454. https:\/\/doi.org\/10.1210\/en.2015-2059","journal-title":"Endocrinology"},{"issue":"4","key":"1678_CR46","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1055\/s-0037-1615748","volume":"79","author":"F Yoo","year":"2018","unstructured":"Yoo F, Chan C, Kuan EC, Bergsneider M, Wang MB (2018) Comparison of male and female prolactinoma patients requiring surgical intervention. J Neurol Surg B Skull Base 79(4):394\u2013400. https:\/\/doi.org\/10.1055\/s-0037-1615748","journal-title":"J Neurol Surg B Skull Base"},{"issue":"3","key":"1678_CR47","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1530\/eje.0.1480325","volume":"148","author":"A Colao","year":"2003","unstructured":"Colao A, Sarno AD, Cappabianca P et al (2003) Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia. Eur J Endocrinol 148(3):325\u2013331. https:\/\/doi.org\/10.1530\/eje.0.1480325","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"1678_CR48","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11102-019-01009-y","volume":"23","author":"H Duskin-Bitan","year":"2020","unstructured":"Duskin-Bitan H, Shimon I (2020) Prolactinomas in males: any differences? Pituitary 23(1):52\u201357. https:\/\/doi.org\/10.1007\/s11102-019-01009-y","journal-title":"Pituitary"},{"issue":"2","key":"1678_CR49","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s12022-016-9418-7","volume":"27","author":"W Saeger","year":"2016","unstructured":"Saeger W, Honegger J, Theodoropoulou M et al (2016) Clinical impact of the current WHO classification of pituitary adenomas. Endocr Pathol 27(2):104\u2013114. https:\/\/doi.org\/10.1007\/s12022-016-9418-7","journal-title":"Endocr Pathol"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01678-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01678-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01678-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:49:40Z","timestamp":1782409780000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-026-01678-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1678"],"URL":"https:\/\/doi.org\/10.1007\/s11102-026-01678-6","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The University of Rochester Research Subjects Review Board (RSRB) approved this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was waived by the University of Rochester Research Subjects Review Board (RSRB) due to the retrospective nature of the study and the use of de-identified data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"92"}}